Alex Brill discussed the Earned Income Tax Credit: “One of the things I note when I think about the federal income tax with respect to low and moderate income workers in the disparity to which the tax code affects different people within that population differently. That’s always true across the income spectrum but it’s particularly true among low and middle income families and households.”
At an event on conservative policies for helping poor and middle-class Americans, Alex Brill discussed how best to promote upward mobility: “I think that in the long run, if we provide some relief or assistance to those workers and those families without the kind of structural reforms that Speaker Ryan was talking about — closing the skills gap and things like that — then what are we going to do ten years from now when those people aren’t moving up through the system?”
From the Coalition to Protect Patient Choice:
“The last panelist was Alex Brill… [who] spoke about FDA reform and specifically about patent issues relating to biologic drugs and their generic counterparts known as biosimilars. He stated that biosimilar entry has not been as robust as was envisioned by the Affordable Care Act, due to archaic regulatory schemes, anticompetitive conduct, and cost-benefit analysis.”
From AEI:
“Alex Brill expressed optimism regarding the incoming Congress’ ability to enact pro-growth tax reform and endorsed the Ryan-Brady tax plan. However, he acknowledged that achieving bipartisan cooperation on this front will be challenging.”
At an event on promoting economic growth amid a populist backlash, Alex Brill discussed the impact of the corporate tax on workers: “Politicians have used the tax policy debate in campaigns for forever, and they generally use tax policy ideas in a very direct way: ‘My tax plan will affect your tax bill this much — directly.’
In an event following the release of FDA’s May 2016 “deeming rule,” which applied tobacco regulations to e-cigarettes, Alex Brill examined Congressional aspects of public policy related to the deeming rule and to e-cigarettes more broadly. Specifically, he looked at what Congress intends to do about e-cigarettes, focusing on three questions: First, what are congressional attitudes about the deeming rule and e-cigarette regulation generally? Second, is it a partisan issue? And third, looking beyond the deeming rule, how will Congress affect e-cigarette use more broadly in the future? “I think that the next battle that Congress will look to tackle with respect to e-cig products is the tax question,” said Brill.
